While GLP-1 receptor agonist therapy leads to greater relative fat loss than lean mass loss, preserving muscle tissue requires adequate protein intake and resistance exercise during weight reduction
These divergent effects appear to be modulated by multiple factors, including treatment duration, drug concentration, cancer type, and patient-specific parameters such as genetic background and comorbidities [9, 19]
GLP-1 agonists have demonstrated significant health benefits in controlling weight, blood glucose, blood pressure, and MACE and continue to show promising outcomes in different clinical trials and meta-analyses
Prog Mol Biol Transl Sci 173:331354 Naik RA et al (2025) The potential mechanism and the role of antioxidants in mitigating oxidative stress in Alzheimers disease
Are there specific B vitamin considerations for men over 60